Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer
Xueting Cai, Miao Jing, Rongwei Sun, Sainan Wang, Miguel Ángel Molina‐Vila, Imane Chaib, Rafael Rosell, Peng Cao
Topics & Concepts
OsimertinibCancer researchT790MChemistryLung cancerGefitinibPharmacologyEpidermal growth factor receptorErlotinibBiologyMedicineBiochemistryInternal medicineReceptorLung Cancer Treatments and MutationsQuinazolinone synthesis and applicationsLung Cancer Research Studies